Outcomes of unrelated cord blood transplantation in patients
Outcomes of unrelated cord blood transplantation in patients with multiple myeloma: a survey on behalf of Eurocord, the Cord Blood Committee of Cellular Therapy and Immunobiology Working Party, and the Chronic Leukemia Working Party of the EBMT by Annalisa Paviglianiti, Erick Xavier, Annalisa Ruggeri, Patrice Ceballos, Eric Deconinck, Jan J. Cornelissen, Stephanie Nguyen-Quoc, Natacha Maillard, Guillermo Sanz, Pierre-Simon Rohrlich, Laurent Garderet, Fernanda Volt, Vanderson Rocha, Nicolaus Kroeger, Eliane Gluckman, Nathalie Fegueux, and Mohamad Mohty haematol Volume 101(9): 1120 -1127 August 31, 2016 © 2016 by Ferrata Storti Foundation
Patients’ characteristics. Annalisa Paviglianiti et al. Haematologica 2016; 101: 11201127 © 2016 by Ferrata Storti Foundation
Transplant characteristics. Annalisa Paviglianiti et al. Haematologica 2016; 101: 11201127 © 2016 by Ferrata Storti Foundation
Univariate analysis of main transplant outcomes. Annalisa Paviglianiti et al. Haematologica 2016; 101: 11201127 © 2016 by Ferrata Storti Foundation
Multivariate analysis. Annalisa Paviglianiti et al. Haematologica 2016; 101: 11201127 © 2016 by Ferrata Storti Foundation
3 -year non-relapse mortality and relapse incidence. Annalisa Paviglianiti et al. Haematologica 2016; 101: 11201127 © 2016 by Ferrata Storti Foundation
3 -year overall survival. Annalisa Paviglianiti et al. Haematologica 2016; 101: 11201127 © 2016 by Ferrata Storti Foundation
3 -year progression-free survival. Annalisa Paviglianiti et al. Haematologica 2016; 101: 11201127 © 2016 by Ferrata Storti Foundation
- Slides: 8